Medical practice M&A is the sale, merger, or ownership change of a physician practice. Before you contact a buyer or a broker, the useful work is deciding which buyer type could fit, which deal shape you could live with, and which decisions you will not hand off. A headline price is not that decision. Two offers with the same number can leave you with very different control, cash, and risk.
Schedule a free consultation to sort buyer types and deal shape before you contact anyone.
This guide stays on that pre-outreach question. It does not walk through a records checklist, a valuation method, letter-of-intent negotiation, or how to pick a broker. Those steps matter later, and other pages cover them. Start here if you want a clear picture of the transaction itself.
What is medical practice M&A?
Medical practice M&A is any transaction that changes who owns or controls a physician practice. That includes a full sale, a merger of two practices, a sale to a health system, and a sale to a private equity-backed group. It also includes a partial sale in which you keep a stake. The label is broad. The decision is specific: who will own the practice, who will control clinical decisions, and how you get paid.
Owners often hear "M&A" and picture a single process with a single kind of buyer. In practice, the first fork is the counterparty. A local physician partner, a hospital, and a private equity platform are not variations of the same offer. They underwrite different things, they pay in different forms, and they expect a different role from you after closing.
Federal antitrust filing is a separate question, and most physician-practice deals never reach it. The Hart-Scott-Rodino Act requires a premerger notification only when a deal crosses size thresholds set in the statute and adjusted over time. The current thresholds and filing fees are published by the Federal Trade Commission. Treat a filing obligation as something your transaction counsel confirms for the actual deal, not as a reason to delay basic preparation.
First Move Advisors is not a broker and not a buyer. The work at this stage is a clear look at the path, before anyone asks you to sign an engagement or an exclusivity period.
Which buyer types show up in medical practice M&A?
Four buyer types account for most physician-practice conversations. They are not a ranking. They are a way to see what each path is actually buying.
| Buyer type | What they usually want | What you should weigh first |
|---|---|---|
| Another physician or local group. | A practice they can operate, often with you staying through a handover. | Fit with your patients and staff, and whether the buyer can actually close. |
| Health system or hospital. | A referral base, coverage, and a long employment or professional-services relationship. | Employment terms, call coverage, and how much clinical control you keep. |
| Private equity-backed platform. | A platform or add-on they can grow and later resell. | Hold period, rollover equity, and who controls the management company. |
| Strategic or specialty group. | A specialty, a geography, or an ancillary line that fills a gap. | Whether your practice stays intact or is absorbed into a larger operation. |
A private equity path has its own economics, including hold period, rollover, and the management-services model. Those belong in a private equity medical practice sale review, not in a first pass at buyer types. If your real question is employment by a hospital versus a sale to another physician, write that down before you take a meeting. The meeting will go better if you already know which path you are testing.
How do deal shapes change what you actually receive?
Buyer type tells you who is across the table. Deal shape tells you what you receive, and when. Three shapes cover most physician-practice transactions.
Asset sale
The buyer purchases selected assets, such as equipment, records where the law allows, and goodwill. The practice entity often stays with you. Buyers like this shape because they can leave unwanted liabilities behind. You should ask which assets are included, which liabilities stay with you, and how patient records and payer contracts actually transfer.
Equity or stock sale
The buyer purchases ownership in the practice entity itself. That can be simpler for contracts that are hard to assign. It can also pass historical liabilities to the buyer, which is why equity deals draw heavier diligence and more negotiation over indemnities. Do not treat "equity sale" as automatically better. Treat it as a different allocation of risk.
Partial sale or merger
You sell some of the ownership, or you combine with another practice and keep a stake. Cash at close is smaller. Ongoing economics, governance, and an eventual second sale matter more. A merger of two independent practices is still medical practice M&A. It still needs a written answer on who decides hiring, compensation, and a later exit.
Inside any of those shapes, price is rarely all cash at close. Earnouts, seller notes, escrow, and rollover equity each move dollars from "paid now" to "paid if." An earnout is a contingent payment tied to results after closing. It deserves its own review in an earnout healthcare M&A discussion once a real term sheet exists. Before outreach, you only need to know which of these tools you would consider and which you would not.
What should you decide before any outreach?
Outreach is a meeting, a teaser, or a broker engagement. Before that, settle four points in writing. They do not need to be polished. They need to be yours.
- Outcome. Full exit, a partial sale, a merger with a peer, or employment by a system. If you want more than one, rank them.
- Timeline. A sale inside a year is a different preparation problem from a sale three years out. Say which one you mean.
- Nonnegotiables. Clinical autonomy, location, which staff stay, and how long you will work after closing. Three items is enough.
- Who speaks for the practice. If there are partners, decide who can take a first meeting and who must approve a next step.
The records you will eventually organize, including financials and a data room, are a separate job. Use the selling a medical practice readiness checklist for that work. Do not let a missing binder stop you from deciding the four points above. Buyers and brokers will fill a blank list with their preferred path.
Which conflicts should you spot before you share information?
The person asking for your numbers is not always working only for you. Name the conflict before you send a file.
- A broker paid at closing is paid if a deal closes. That is a real incentive to get you to a transaction, and it can sit in tension with a decision to wait. Ask how they are paid, by whom, and what happens if you stop.
- A buyer in a first meeting is underwriting a purchase. Their view of value is an opening position, not an appraisal. A flattering number with a long exclusivity period is still a negotiation.
- An advisor paid a fixed fee by you is paid whether or not you sell. That does not make the advice perfect. It does mean the fee does not depend on you signing a deal.
Choosing among brokers is its own decision, covered in medical practice brokers. The question here is narrower. Before you share payer mix, provider production, or a partner agreement, know whether the recipient is paid to close, paid to buy, or paid by you.
Also decide what you will not send in a first conversation. A high-level specialty, geography, provider count, and revenue range is enough to test fit. Patient-level detail, staff names, and unsigned internal disputes can wait until you have a confidentiality agreement you have actually read.
How do state rules change who can own the practice?
Some states limit who may own a medical practice or employ physicians. These corporate practice of medicine rules vary by state, and a structure that is ordinary in one state can be restricted in another. The American Medical Association has described growing state action aimed at corporate ownership and control of medical practices. That is a legal question for counsel in your state. It is also a practical question for you, because it decides which buyer types are even available.
Ask two plain questions before outreach. First, can the buyer you have in mind own the practice entity directly in your state? Second, if they cannot, what entity would employ the physicians, and who would control its decisions? A management-services arrangement can be a normal part of a transaction. It can also move control of staffing, payer contracts, and nonclinical operations away from the physicians. You should know which version you are looking at before you agree to a process.
Federal fraud-and-abuse rules sit alongside state ownership rules. Arrangements that pay for referrals, or that tie compensation to volume in a prohibited way, can create Stark and anti-kickback exposure. The HHS Office of Inspector General publishes a plain-language overview of those laws for physicians. You do not need to brief the statutes yourself. You do need a healthcare attorney to look at any proposed employment, lease, or management agreement before you treat it as routine.
What belongs in a first conversation, and what does not?
A first conversation should test fit. It should not set your price, your structure, or your exclusivity.
Useful topics are the buyer's experience with your specialty, the role they expect from you after closing, and the form of consideration they typically use. Ask whether they buy assets or equity, whether physicians keep a stake, and how long a typical process runs from first meeting to a signed letter of intent. Vague answers are information. So is pressure to sign something at the end of the call.
Leave these for later, on purpose:
- A negotiated purchase price. You do not yet have a normalized earnings picture to stand on. Normalized EBITDA is the figure serious buyers test, and it is a preparation project of its own.
- Letter-of-intent terms, including exclusivity and escrow. Those are covered once a real proposal exists, in a letter of intent healthcare M&A review.
- A commitment to one broker or one buyer. Exclusivity is a trade. Make it after you know what you are trading away.
If a conversation jumps straight to a number and a signature, you can pause it. Preparation is not a delay tactic. It is how you keep the first number from becoming the only number.
When is a medical practice M&A conversation worth starting?
Start the conversation when you can answer the four pre-outreach points and you know which buyer type you are willing to test. You do not need a finished valuation, a data room, or a chosen broker. You do need enough clarity that a flattering meeting cannot rewrite your goals.
Wait if any of these are true:
- Partners disagree on whether to sell, merge, or stay independent.
- You cannot explain, in a page, what would make an offer acceptable.
- You are talking to a buyer because they called, not because their path matches a decision you have made.
A free, low-pressure look at buyer type and deal shape is a reasonable first step when you are inside a year of a possible sale or still a few years out. The point of that conversation is a clearer set of options, not a listing agreement.
Before you compare offers, schedule a free consultation and pressure-test the path you are actually considering.
Frequently asked questions
What does medical practice M&A include?
It includes a full sale, a partial sale, a merger with another practice, a sale to a health system, and a sale to a private equity-backed group. The common thread is a change in who owns or controls the practice, not a single contract form.
Do I need a broker before I learn the deal shapes?
No. Buyer type and deal shape are decisions you can frame before you hire anyone. A broker is one way to reach buyers later. Choosing one is a separate step from understanding the transaction.
Is an asset sale better than an equity sale?
Neither is better in the abstract. An asset sale lets a buyer pick what it takes. An equity sale transfers the entity and usually draws more scrutiny of historical liabilities. The better shape is the one that matches the contracts, the risk, and the cash you need.
Should I talk to a private equity buyer first?
Only if a platform sale is a path you are willing to consider. Private equity buyers move on a timetable and often ask for exclusivity early. If you have not decided that this path fits, take the educational meeting and do not sign a process document.
Does preparation mean I have decided to sell?
No. Deciding your outcome, timeline, and nonnegotiables is useful even if you later stay independent. It keeps a future conversation from starting on someone else's terms.